{{Distinguish|Prednisone}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 477172058
| IUPAC_name = (11β)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
| image = Prednisolone-2D-skeletal.svg
| image2 = Prednisolone-3D-balls.png
<!--Clinical data-->
| tradename = many
| Drugs.com = {{drugs.com|monograph|prednisolone}}
| MedlinePlus = a682794
| pregnancy_AU = A
| pregnancy_US = C
| legal_UK = POM
| legal_US = Rx-only
| licence_US = prednisolone
<!--Pharmacokinetic data-->
| elimination_half-life = 2–3 hours
| excretion = [[urine]]
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 50-24-8
| ATC_prefix = A07
| ATC_suffix = EA01
| ATC_supplemental =  {{ATC|C05|AA04}}, {{ATC|D07|AA03}}, {{ATC|H02|AB06}}, {{ATC|R01|AD02}}, {{ATC|S01|BA04}}, {{ATC|S02|BA03}}, {{ATC|S03|BA02}}
| PubChem = 5755
| IUPHAR_ligand = 2866
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00860
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5552
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9PHQ9Y1OLM
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00472
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8378
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 131
<!--Chemical data-->
| C=21 | H=28 | O=5
| molecular_weight = 360.444 g/mol
| smiles = O=C\1\C=C/[C@]4(/C(=C/1)CC[C@@H]2[C@@H]4[C@@H](O)C[C@@]3([C@@](O)(C(=O)CO)CC[C@@H]23)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OIGNJSKKLXVSLS-VWUMJDOOSA-N
| synonyms = <small>11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydrocyclopenta[a] phenanthren-3-one</small>
}}
<!-- Definition and medical uses -->
'''Prednisolone''' is a [[corticosteroid|steroid medication]] used to treat certain types of [[allergies]], [[inflammation|inflammatory conditions]], [[autoimmune disorders]], and [[cancer]]s.<ref name=WHO2008>{{cite book|title=WHO Model Formulary 2008|date=2009|publisher=World Health Organization|isbn=9789241547659|pages=53–54|url=http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|accessdate=8 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161213060118/http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|archivedate=13 December 2016|df=}}</ref><ref name=AHFS2016/> Some of these conditions include [[adrenocortical insufficiency]], [[hypercalcemia|high blood calcium]], [[rheumatoid arthritis]], [[dermatitis]], eye inflammation, [[asthma]], and [[multiple sclerosis]].<ref name=AHFS2016/> It is used by mouth, [[intravenous|injection into a vein]], as a skin cream, and as [[eye drops]].<ref>{{cite web|title=Search results – (eMC)|url=https://www.medicines.org.uk/emc/search/?q=Prednisolone&a=330,2470,969,739|website=www.medicines.org.uk|accessdate=13 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161220175326/https://www.medicines.org.uk/emc/search/?q=Prednisolone&a=330,2470,969,739|archivedate=20 December 2016|df=}}</ref>

<!-- Side effects and mechanism -->
Side effects with short term use include nausea and feeling tired.<ref name=WHO2008/> More severe side effects include psychiatric problems, which may occur in about 5% of people.<ref name=ER2014>{{cite web|title=Pevanti 10mg Tablets – Summary of Product Characteristics (SPC) – (eMC)|url=https://www.medicines.org.uk/emc/medicine/30014|date=1 December 2014|website=www.medicines.org.uk|accessdate=13 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161220175357/https://www.medicines.org.uk/emc/medicine/30014|archivedate=20 December 2016|df=}}</ref> Common side effects with long term use include [[osteoporosis|bone loss]], weakness, [[candidiasis|yeast infections]], and easy bruising.<ref name=AHFS2016/> While short term use in the later part of [[pregnancy]] is safe, use long term or early in early pregnancy is occasionally associated with harm to the baby.<ref>{{cite web|title=Prednisolone Use During Pregnancy {{!}} Drugs.com|url=https://www.drugs.com/pregnancy/prednisolone.html|website=www.drugs.com|accessdate=13 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161221002545/https://www.drugs.com/pregnancy/prednisolone.html|archivedate=21 December 2016|df=}}</ref> It is a [[glucocorticoid]] made from [[hydrocortisone]] (cortisol).<ref name=Kim2016/>

<!-- History, society and culture -->
Prednisolone was discovered and approved for medical use in 1955.<ref name=Kim2016>{{cite book|last1=Kim|first1=Kyu-Won|last2=Roh|first2=Jae Kyung|last3=Wee|first3=Hee-Jun|last4=Kim|first4=Chan|title=Cancer Drug Discovery: Science and History|date=2016|publisher=Springer|isbn=9789402408447|page=169|url=https://books.google.com/books?id=BR9_DQAAQBAJ&pg=PA169|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170910174620/https://books.google.com/books?id=BR9_DQAAQBAJ&pg=PA169|archivedate=2017-09-10|df=}}</ref> It is on the [[World Health Organization's List of Essential Medicines]], the most effective and safe medicines needed in a [[health system]].<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref> It is available as a generic medication.<ref name=AHFS2016>{{cite web|title=Prednisolone|url=https://www.drugs.com/monograph/prednisolone.html|publisher=The American Society of Health-System Pharmacists|accessdate=8 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161223131831/https://www.drugs.com/monograph/prednisolone.html|archivedate=23 December 2016|df=}}</ref> The wholesale cost in the [[developing world]] is about 0.01 to 0.02 USD per day.<ref name=ERC2014>{{cite web|title=Prednisolone|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=PRE5T&s_year=2014&year=2014&str=5%20mg&desc=Prednisolone&pack=new&frm=TAB-CAP&rte=PO&class_code2=08%2E3%2E&supplement=&class_name=%2803%2E%29Antiallergics%20and%20medicines%20used%20in%20anaphylaxis%3Cbr%3E%2808%2E3%2E%29Hormones%20and%20antihormones%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=8 December 2016}}</ref>

==Medical uses==
Prednisolone is a [[corticosteroid]] drug with predominant [[glucocorticoid]] and low [[mineralocorticoid]] activity, making it useful for the treatment of a wide range of inflammatory and [[autoimmunity|autoimmune]] conditions<ref>{{cite journal |vauthors=Czock D, Keller F, Rasche FM, Häussler U | year = 2005 | title = Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids | url = | journal = Clin Pharmacokinet | volume = 44 | issue = 1| pages = 61–98 | pmid = 15634032 | doi=10.2165/00003088-200544010-00003}}</ref> such as [[asthma]],<ref>{{cite journal |vauthors=Fiel SB, Vincken W | date = Jun 2006 | title = Systemic corticosteroid therapy for acute asthma exacerbations | url = | journal = J Asthma | volume = 43 | issue = 5| pages = 321–31 | doi = 10.1080/02770900600567163 | pmid = 16801135 }}</ref> [[uveitis]], [[pyoderma gangrenosum]], [[rheumatoid arthritis]], [[ulcerative colitis]], [[pericarditis]], [[temporal arteritis]] and [[Crohn's disease]], [[Bell's palsy]], [[multiple sclerosis]],<ref>{{cite journal | author = Thrower BW | date = Jan 2009 | title = Relapse management in multiple sclerosis | url = | journal = Neurologist | volume = 15 | issue = 1| pages = 1–5 | doi = 10.1097/NRL.0b013e31817acf1a | pmid = 19131851 }}</ref> [[cluster headaches]], [[vasculitis]], [[acute lymphoblastic leukemia]] and [[autoimmune hepatitis]],<ref>{{cite journal |vauthors=Lambrou GI, Vlahopoulos S, Papathanasiou C, Papanikolaou M, Karpusas M, Zoumakis E, Tzortzatou-Stathopoulou F | year = 2009 | title = Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression | url = | journal = Leuk Res. | volume = 33| issue = 12| pages = 1684–95| doi = 10.1016/j.leukres.2009.04.018 | pmid = 19450877 }}</ref> [[systemic lupus erythematosus]], [[Kawasaki disease]],<ref>{{cite journal |vauthors=Miura M, Tamame T, Naganuma T, Chinen S, Matsuoka M, Ohki H | year = 2011 | title = Steroid pulse therapy for Kawasaki disease unresponsive to additional immunoglobulin therapy | url = | journal = Paediatrics & Child Health | volume = 16 | issue = 8| pages = 479–84 | pmid = 23024586 | pmc=3202387}}</ref> [[dermatomyositis]],<ref name="Cima Labs Inc 2006">Product Information: ORAPRED ODT(TM) orally
disintegrating tablets, prednisolone sodium phosphate orally disintegrating
tablets. Cima Labs Inc, Alpharetta, GA, 2006.</ref> and [[sarcoidosis]].<ref>{{Cite journal|title = Acute alveolar sarcoidosis presenting with hypoxaemic respiratory failure|url = http://casereports.bmj.com/content/2014/bcr-2013-202247|journal = BMJ Case Reports|date = 2014-04-30|issn = 1757-790X|pmc = 4024548|pmid = 24789154|pages = bcr2013202247|volume = 2014|doi = 10.1136/bcr-2013-202247|first = Kamal|last = Gera|first2 = Nitesh|last2 = Gupta|first3 = Anuradha|last3 = Ahuja|first4 = Ashok|last4 = Shah|deadurl = no|archiveurl = https://web.archive.org/web/20160420042340/http://casereports.bmj.com/content/2014/bcr-2013-202247|archivedate = 2016-04-20|df = }}</ref>

Prednisolone acetate ophthalmic suspension (eye drops) is an adrenocortical steroid product, prepared as a sterile ophthalmic suspension and used to reduce swelling, redness, itching, and [[Allergy|allergic reactions]] affecting the eye.<ref>{{Cite web|url =http://www.allergan.com/assets/pdf/pred_forte_pi.pdf|title =Pred Forte Package Insert|date =|accessdate =|website =|publisher =|deadurl =no|archiveurl =https://web.archive.org/web/20160304095704/http://www.allergan.com/assets/pdf/pred_forte_pi.pdf|archivedate =2016-03-04|df =}}</ref><ref>Product Information: OMNIPRED(TM) ophthalmic
suspension, prednisolone acetate ophthalmic suspension. Alcon Laboratories Inc,
Fort Worth, TX, 2005</ref> It has been explored as a treatment option for [[keratitis|bacterial keratitis]].<ref name="Herretes">{{cite journal |author= Herretes S, Wang X, Reyes JMG |title= Topical corticosteroids as adjunctive therapy for bacterial keratitis |journal=Cochrane Database Syst Rev|volume= |issue=10 |pages= CD005430 |date=2014 |pmid= 25321340|doi= 10.1002/14651858.CD005430.pub3}}</ref>

Prednisolone can also be used for allergic reactions ranging from seasonal allergies to [[Drug allergy|drug allergic]] reactions.<ref name=":0">{{Cite web|url = http://www.laserpharmaceuticals.com/mydocuments/millipred_os_package_insert.pdf.|title = Millipred tablets package insert|date = |accessdate = |website = |publisher = }}</ref>

Prednisolone can also be used as an [[immunosuppressive]] drug for [[organ transplants]].<ref name="Cima Labs Inc 2006"/><ref>{{Cite journal|title = Legemiddelinteraksjoner og immunsuppresjon hos organtransplanterte|url = http://tidsskriftet.no/article/2155759|journal = Tidsskrift for Den norske legeforening|pages = 2000–2003|volume = 131|issue = 20|doi = 10.4045/tidsskr.11.0138|first = Nils|last = Vethe|first2 = Karsten|last2 = Midtvedt|first3 = Anders|last3 = Åsberg|first4 = Rune|last4 = Amundsen|first5 = Stein|last5 = Bergan|deadurl = no|archiveurl = https://web.archive.org/web/20160304122116/http://tidsskriftet.no/article/2155759|archivedate = 2016-03-04|df = }}</ref>

Prednisolone in lower doses can be used in cases of primary adrenal insufficiency ([[Addison's disease]]).<ref>{{Cite journal|title = Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency|url = http://onlinelibrary.wiley.com/doi/10.1111/joim.12162/abstract|journal = Journal of Internal Medicine|date = 2014-02-01|issn = 1365-2796|pages = 104–115|volume = 275|issue = 2|doi = 10.1111/joim.12162|first = E. S.|last = Husebye|first2 = B.|last2 = Allolio|first3 = W.|last3 = Arlt|first4 = K.|last4 = Badenhoop|first5 = S.|last5 = Bensing|first6 = C.|last6 = Betterle|first7 = A.|last7 = Falorni|first8 = E. H.|last8 = Gan|first9 = A.-L.|last9 = Hulting|deadurl = no|archiveurl = https://web.archive.org/web/20160505113237/http://onlinelibrary.wiley.com/doi/10.1111/joim.12162/abstract|archivedate = 2016-05-05|df = }}</ref><ref>AMA Department of Drugs: AMA Drug Evaluations, 6th.
American Medical Association, Chicago, IL, 1986.</ref>

Corticosteroids inhibit the inflammatory response to a variety of inciting agents and, it is presumed, delay or slow healing.<ref>{{Cite journal|title = Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions|url = https://www.ncbi.nlm.nih.gov/pubmed/?term=Glucocorticosteroid+inhibition+of+cytokine+production%253A+relevance+to+antiallergic+actions|journal = The Journal of Allergy and Clinical Immunology|date = 1996-01-01|issn = 0091-6749|pmid = 8568145|pages = 143–152|volume = 97|issue = 1 Pt 2|first = L. M.|last = Schwiebert|first2 = L. A.|last2 = Beck|first3 = C.|last3 = Stellato|first4 = C. A.|last4 = Bickel|first5 = B. S.|last5 = Bochner|first6 = R. P.|last6 = Schleimer|first7 = L. A.|last7 = Schwiebert|doi = 10.1016/s0091-6749(96)80214-4|deadurl = no|archiveurl = https://web.archive.org/web/20170910174620/https://www.ncbi.nlm.nih.gov/pubmed/?term=Glucocorticosteroid+inhibition+of+cytokine+production%253A+relevance+to+antiallergic+actions|archivedate = 2017-09-10|df = }}</ref> They inhibit the edema, fibrin deposition, capillary dilation, [[White blood cell|leukocyte]] migration, capillary proliferation, fibroblast proliferation, deposition of [[collagen]], and scar formation with inflammation.<ref>{{Cite journal|title = Mechanisms of Glucocorticoid Action in Chronic Rhinosinusitis|url = http://synapse.koreamed.org/DOIx.php?id=10.4168/aair.2015.7.6.534|journal = Allergy, Asthma & Immunology Research|pmc = 4605925|pmid = 26333699|volume = 7|issue = 6|doi = 10.4168/aair.2015.7.6.534|first = Sang Hag|last = Lee|pages=534–7|year=2015}}</ref>

==Adverse effects==
There are several adverse reactions from the use of prednisolone:
* Increased appetite, weight gain, nausea and [[malaise]]
* Increased risk of infection 
* [[Cardiovascular disease|Cardiovascular]] events in children
* Dermatological effects including reddening of face, bruising/skin discoloration, impaired wound healing, thinning of skin, skin rash, fluid build up and abnormal hair growth 
* [[Hyperglycemia]]; patients with diabetes may need increased [[insulin]] or diabetic therapies
* Menstrual abnormalities 
* Less response to hormones, especially during stressful instances such as surgery or illness
* Change in electrolytes: rise in [[blood pressure]], increased sodium and low potassium, leading to [[alkalosis]] 
* GI system effects: swelling of stomach lining, reversible increase in liver enzymes and risk of [[Peptic ulcer|stomach ulcers]]
* Muscular and skeletal abnormalities, such as muscle weakness/muscle loss, [[osteoporosis]], long bone fractures, tendon rupture and back fractures
* Neurological effects, including involuntary movements ([[convulsion]]s), headaches and [[vertigo]]   
* Behavioral disturbances <ref name=":2" />   
Nasal septum perforation and bowel perforation are also notable adverse effects that restrict steroid use in some pathologic conditions.<ref>{{cite journal | pmc = 1347010 | pmid=7425698 | volume=192 | title=Bowel perforation in steroid-treated patients | author=ReMine SG, McIlrath DC | journal=Ann Surg | pages=581–6 | doi=10.1097/00000658-198010000-00016}}</ref><ref>{{cite journal | pmid = 9830677 | volume=36 | title=Intranasal steroids and septum perforation--an overlooked complication? A description of the course of events and a discussion of the causes | author=Cervin A, Andersson M | journal=Rhinology | pages=128–32}}</ref>

Withdrawal from prednisolone after long-term or high-dose use can lead to [[adrenal insufficiency]].<ref name=":2" />

===Pregnancy and breastfeeding ===
Although there are no major human studies of prednisolone use in pregnant women, studies in several animals show that it may cause birth defects including increase [[Cleft lip and palate|cleft palate]]. Prednisolone should be used in pregnant women when benefits outweigh the risks and children born from mothers using prednisolone during pregnancy should be monitored for impaired adrenal function.

Prednisolone is found in breast milk of mothers taking prednisolone.<ref name=":2">{{Cite web|url =http://products.sanofi.ca/en/pediapred.pdf|title =PEDIAPRED|date =|accessdate =|website =|publisher =|deadurl =no|archiveurl =https://web.archive.org/web/20160304223644/http://products.sanofi.ca/en/pediapred.pdf|archivedate =2016-03-04|df =}}</ref>

==Pharmacology==
As a [[glucocorticoid]], the lipophilic structure of prednisolone allows for easy passage through the cell membrane where it then binds to its respective [[glucocorticoid receptor]] (GCR) located in the cytoplasm. Upon binding, formation of the GC/GCR complex causes dissociation of [[Chaperone (protein)|chaperone proteins]] from the glucocorticoid receptor enabling the GC/GCR complex to translocate inside the nucleus. This process occurs within 20 minutes of binding.  Once inside the nucleus, the [[Protein dimer|homodimer]] GC/GCR complex binds to specific DNA binding-sites known as glucocorticoid response elements (GREs) resulting in gene expression or inhibition.  Complex binding to positive GREs leads to synthesis of anti-inflammatory proteins while binding to negative GREs block the [[Transcription (genetics)|transcription]] of inflammatory genes.<ref>{{Cite journal|url = http://ac.els-cdn.com/S0303720707002110/1-s2.0-S0303720707002110-main.pdf?_tid=3ad5455a-827d-11e5-b74d-00000aab0f26&acdnat=1446591187_d76fcee3317cd77021dada53514f4310|title = Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists|last = Stahn|first = Cindy|date = 17 May 2007|journal = Molecular and Cellular Endocrinology|doi = 10.1016/j.mce.2007.05.019|pmid = |access-date =|volume=275|pages=71–78}}</ref>

==Chemistry==
Prednisolone is a [[synthetic compound|synthetic]] [[pregnane]] [[corticosteroid]] and [[chemical derivative|derivative]] of [[cortisol]] (hydrocortisone) and is also known as '''δ<sup>1</sup>-cortisol''', '''δ<sup>1</sup>-hydrocortisone''', '''1,2-dehydrocortisol''', or '''1,2-dehydrohydrocortisone''', as well as '''11β,17α,21-trihydroxypregna-1,4-diene-3,20-dione'''.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA1011|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=1011–1012|deadurl=no|archiveurl=https://web.archive.org/web/20170910174620/https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA1011|archivedate=10 September 2017|df=}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA869|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=869–|deadurl=no|archiveurl=https://web.archive.org/web/20170910174620/https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA869|archivedate=2017-09-10|df=}}</ref>

==Society and culture==

===Dosage forms===
In the United States:

* [[Prednisolone sodium phosphate]] oral solution (Pediapred)<ref name=":2" />
* Prednisolone acetate oral suspension (Flo-Pred)<ref>{{Cite web|url =http://flopred.com/PDF/Flopred_PI.pdf|title =Flo-Pred Package Insert|date =|accessdate =|website =|publisher =|deadurl =no|archiveurl =https://web.archive.org/web/20160304082628/http://flopred.com/PDF/Flopred_PI.pdf|archivedate =2016-03-04|df =}}</ref>
* Prednisolone oral  tablets (Millipred)<ref name=":0" />  
* Prednisolone sodium phosphate oral dissolving tablets (Orapred)<ref>{{Cite web|url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021959s003lbl.pdf|title =Package Insert for Orapred ODT|date =|accessdate =|website =|publisher =|deadurl =no|archiveurl =https://web.archive.org/web/20160304064156/http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021959s003lbl.pdf|archivedate =2016-03-04|df =}}</ref>

===Athletics===
As a glucocorticosteroid, unauthorized or ad-hoc use of prednisolone during competition via oral, intravenous, intramuscular or rectal routes is banned under [[World Anti-Doping Agency|WADA]] anti-doping rules.<ref name=":1">{{Cite web |title=The 2011 Prohibited List |url=http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/International-Standards/Prohibited-List/The-2011-Prohibited-List/Prohibited-In-Competition/ |deadurl=no |archiveurl=https://web.archive.org/web/20110808210916/http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/International-Standards/Prohibited-List/The-2011-Prohibited-List/Prohibited-In-Competition/ |archivedate=2011-08-08 |df= }}</ref> The drug may be used in competition with a TUE (Therapeutic Use Exemption), in compliance with WADA regulations.  Local or topical use of prednisolone during competition as well as any use out of competition is not regulated.<ref name=":1" />

==Veterinary uses==
Prednisolone is used in the treatment of inflammatory and allergic conditions in [[cat]]s, [[dog]]s, and [[ferret]]s.

==See also==
* [[Methylprednisolone]]
* [[Loteprednol]]

==References==
{{Reflist}}

{{Navboxes
| title = [[Medicine|Medical uses]]
| titlestyle = background:#ccccff
| list1 = 
{{Glucocorticoids and antiglucocorticoids}}
{{Antidiarrheals, intestinal anti-inflammatory/anti-infective agents}}
{{Vasoprotectives}}
{{Nasal preparations}}
{{Otologicals}}
}}
{{Navboxes
| title = [[Pharmacodynamics]]
| titlestyle = background:#ccccff
| list1 = 
{{Glucocorticoid receptor modulators}}
{{Mineralocorticoid receptor modulators}}
{{Xenobiotic-sensing receptor modulators}}
}}

[[Category:Glucocorticoids]]
[[Category:Mineralocorticoids]]
[[Category:Otologicals]]
[[Category:World Health Organization essential medicines]]
[[Category:Human drug metabolites]]
[[Category:RTT]]

[[ko:프레드니솔론]]
[[hy:Պրեդնիզոլոն]]